Publication:
Survival of Huntington's disease patients in Serbia: Longer survival in female patients

dc.contributor.authorPekmezovic, Tatjana (7003989932)
dc.contributor.authorSvetel, Marina (6701477867)
dc.contributor.authorMaric, Jelena (6602218323)
dc.contributor.authorDujmovic-Basuroski, Irena (6701590899)
dc.contributor.authorDragasevic, Natasa (59157743200)
dc.contributor.authorKeckarevic, Milica (18434375900)
dc.contributor.authorRomac, Stanka (7003983993)
dc.contributor.authorKostic, Vladimir S. (35239923400)
dc.date.accessioned2025-06-13T00:04:13Z
dc.date.available2025-06-13T00:04:13Z
dc.date.issued2007
dc.description.abstractThe objective of this study was to estimate probability of survival of Huntington's disease (HD) patients in Serbia as a function of CAG repeat length and selected demographic variables. This follow-up study was carried out at the Institute of Neurology, Clinical Centre of Serbia, Belgrade, 1982-2004. The study group consisted of 112 HD patients. The significant inverse correlation was found between CAG repeat length and age at onset of HD (r = -0.732, P = 0.001) and age at death (r = -0.760, P = 0.001). The cumulative probabilities of survival in a five, ten, fifteen, and twenty-years' period were 90.9, 63.2, 10.3 and 4.5%, respectively. Higher survival probabilities were registered in female patients, as well as in those with older age at onset and lower number of CAG repeat length (≤46). The Cox regression analysis showed that significantly poorer outcome of HD in our population was related to younger age at onset (HR-hazard ratio = 1.9; P = 0.047), and larger CAG numbers (HR = 2.4; P = 0.071). The female sex was statistically significantly associated with longer survival (HR = 0.4; P = 0.007). These data might be of some importance for further exploration of natural history and prognosis of HD. © 2007 Springer Science+Business Media B.V.
dc.identifier.urihttps://doi.org/10.1007/s10654-007-9157-7
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-34547651414&doi=10.1007%2fs10654-007-9157-7&partnerID=40&md5=39ebe13868d616cb40c9fb9e0e98e14c
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/10846
dc.subjectAge
dc.subjectCAG repeat length
dc.subjectFemale sex
dc.subjectHuntington's disease
dc.subjectPrognosis
dc.subjectSurvival
dc.titleSurvival of Huntington's disease patients in Serbia: Longer survival in female patients
dspace.entity.typePublication

Files